Ventilator-associated pneumonia. Diagnosis, pathogenesis and prevention

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pulmonary Medicine

Background:

• Ventilator-associated pneumonia (VAP) is a frequent complication in critically ill patients requiring prolonged mechanical ventilation.
• Pathogenic bacteria colonize the oropharynx, sinuses, and stomach, leading to pooled secretions that can enter the lower airways.
• Aspiration of these secretions past the tracheal tube cuff overwhelms host defenses, causing inflammation and infection.

Purpose of the Study:

• To define ventilator-associated pneumonia (VAP) and its pathogenesis.
• To outline the pathological characteristics of VAP.
• To identify key strategies for VAP prevention.

Main Methods:

• The abstract describes the pathological process and etiological factors of VAP.
• It outlines the clinical definition based on the timing of the inflammatory response post-intubation.
• Prevention strategies are discussed based on understanding pathogen reservoirs and aspiration risks.

Main Results:

• VAP is characterized by inflammation in bronchioles and alveoli, including capillary congestion and inflammatory cell infiltration.
• The inflammatory response occurring >48 hours after intubation is defined as VAP.
• Colonization of the upper airway and stomach, and aspiration past the endotracheal tube cuff are key events.

Conclusions:

• VAP is a common, high-mortality complication of mechanical ventilation.
• Prevention requires reducing bacterial colonization in the upper airway and gastrointestinal tract.
• Minimizing aspiration past the tracheal tube cuff and enhancing bacterial clearance are crucial for VAP prevention.